Drug Shortage Report for IRBESARTAN/HCTZ
| Report ID | 42112 |
| Drug Identification Number | 02372908 |
| Brand name | IRBESARTAN/HCTZ |
| Common or Proper name | IRBESARTAN/HCTZ |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 25MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-03-12 |
| Actual start date | 2018-03-12 |
| Estimated end date | 2018-04-30 |
| Actual end date | 2018-04-12 |
| Shortage status | Resolved |
| Updated date | 2018-04-13 |
| Company comments | Delay in availability of replenishment batch |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2018-04-13 | English | Compare |
| v7 | 2018-04-12 | French | Compare |
| v6 | 2018-04-12 | English | Compare |
| v5 | 2018-03-13 | French | Compare |
| v4 | 2018-03-13 | English | Compare |
| v3 | 2018-03-13 | English | Compare |
| v2 | 2018-03-07 | French | Compare |
| v1 | 2018-03-07 | English | Compare |
Showing 1 to 8 of 8